Pharmaceutical company Dr Reddy's, which is developing a Covid-19 vaccine, says it has been hit by a cyber-attack. Sites around the world have been affected, including those in the UK, Brazil ...
This stability provides a solid foundation for the company's core business, allowing it to focus on volume growth and market share expansion. One of the most promising aspects of Dr. Reddy's ...
1993 was the year when Dr. Reddy’s Research Foundation was set up. In 1998, Dr. Reddy's Laboratories launched its Biologics business. The company’s shares were listed on the New York Stock ...
(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) said that it has launched Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.